Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: Results in six patients
- 1 May 1993
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 4 (5) , 429-431
- https://doi.org/10.1093/oxfordjournals.annonc.a058527
Abstract
Locally advanced malignant thymomas are usually radically resectable in about 60% of stage III but hardly ever in stage IVA. Neoadjuvant chemotherapy followed by surgery could improve both resection rate and curability. Cisplatin containing regimens have repeatedly been found to be highly active in advanced disease, with overall response rates ranging from 80%–90%. 3 patients with stage III and 3 with stage IVA invasive thymomas, according to Masaoka staging, entered the study. Histology was: lymphoepithelial 4 cases, epithelial 2 cases. 4 cycles of the ADOC scheme - Adriamycin (40 mg/sqm), cisplatin (50 mg/sqm) on day 1, vincristine (0.6 mg/sqm) on day 2, and cyclophosphamide (700 mg/ sqm) on day 3, every 21 days - were administered to 5 patients, while 1 patient received 5 cycles. 5/6 patients (83.3%) attained partial responses and underwent radical surgery followed by two further ADOC cycles. The disease-free intervals were 5+, 6+, 15+, 16+, 26+ months. One patient showing stable disease at the end of the fifth cycle was referred to radiotherapy. Toxicity was tolerable: grade III (WHO) nausea/vomiting and leukopenia grade III occurred in 2 patients each. These results suggest that the ADOC scheme is active as a neoadjuvant approach in invasive thymoma stages III and IVA, rendering possible radical resectability in 83% of patients.Keywords
This publication has 11 references indexed in Scilit:
- Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymomaCancer, 1991
- Chemotherapy for invasive thymoma. A 13-year experienceCancer, 1991
- Role of staging in prognosis and management of thymomaThe Annals of Thoracic Surgery, 1991
- Neo-Adjuvant treatment in locally advanced thymomaPublished by Springer Nature ,1991
- Thymoma: Results of 241 operated casesThe Annals of Thoracic Surgery, 1991
- Analysis of prognostic factors and clinicopathological staging of thymomaThe Annals of Thoracic Surgery, 1990
- A proposal for treatment of invasive thymomaCancer, 1986
- Thymomas: A review of 169 cases, with particular reference to results of surgical treatmentCancer, 1986
- Chemotherapy of malignant thymoma. Case report and review of the literatureCancer, 1986
- Follow-up study of thymomas with special reference to their clinical stagesCancer, 1981